Viewing Study NCT03778593


Ignite Creation Date: 2025-12-25 @ 1:14 AM
Ignite Modification Date: 2026-01-05 @ 5:58 PM
Study NCT ID: NCT03778593
Status: COMPLETED
Last Update Posted: 2021-02-04
First Post: 2018-12-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: FOLFIRINOX for 2nd-line Treatment of BTC
Sponsor: Dong-A University Hospital
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: GF BTC-2018
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators